Dr. Anna Berry, MD

A Molecular Pathologist with a passion for advancing oncology care, Dr. Anna Berry has spent the past several decades immersed in the field. A graduate of the University of Nebraska Medical Center, Dr. Berry completed her AP/CP pathology training at SUNY Upstate Medical University and Virginia Commonwealth University, followed by MGP fellowship training at VCU and Cytopathology fellowship training at the National Cancer Institute. Dr. Berry has previously served as the inaugural Director of Molecular Pathology and the founding Director of the Molecular Genetic Pathology fellowship training program at UCSF. Next, she served as the Director of Molecular Pathology at CellNetix, while concurrently serving as the Scientific Director for the Personalized Medicine Program at the Swedish Cancer Institute in Seattle. This experience led to an opportunity to accelerate the adoption of precision oncology through the use of Real-World Evidence at Syapse, where Dr. Berry is currently the Senior Vice President for Molecular Medicine and Customer Insights.